[Frontiers in Bioscience 17, 1715-1728, January 1, 2012]

The role of shelterin in maintaining telomere integrity

Maria Pia Longhese1, Savani Anbalagan1, Marina Martina1, Diego Bonetti1

1Dipartimento di Biotecnologie e Bioscienze, Universita di Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy


1. Abstract
2. Introduction
3. The cellular response to DNA double-strand breaks
4. Checkpoint and DNA repair proteins at telomeres
5. The shelterin complex
6. Shelterin dysfunctions and the DNA damage response
7. How does shelterin hide chromosome ends?
8. Regulation of telomere length by shelterin
9. Summary and perspectives
10. Acknowledgements
11. References


The ends of eukaryotic chromosomes need to be protected from detection as DNA double strand breaks by the DNA damage response pathways. Failure to do so would have devastating consequences for genome integrity. Packaging of chromosome ends into protective structures called telomeres prevents checkpoint activation and DNA repair/recombination activities. Several studies on a variety of organisms have revealed that protein complexes with specificity for telomeric DNA protect chromosome ends from being recognized as DNA double-strand breaks and regulate telomere maintenance by the telomerase. In this review, we will discuss the consequences of telomere dysfunction and our understanding of how telomere integrity is maintained.


Before the discovery of the double-helical structure of DNA, Hermann Muller and Barbara McClintock, working with fruit flies and maize, respectively, documented that native ends of linear eukaryotic chromosomes, unlike those arising from breakage at internal chromosome regions, were protected from joining reactions (1,2). In 1938, Muller called these protected DNA ends "telomeres" (from the Greek "telos" meaning end, and "meros" meaning part). Thus, by the first half of the century it was clear that the natural chromosome ends had special properties and structures that protected them from the frequent rearrangements that occur at broken DNA ends. This protective function, referred to as telomere "capping", depends on the presence of species-specific telomeric repeats, telomere-associated proteins and a proper terminal DNA end-structure.

The nature of the DNA sequences that confer telomere function on chromosome ends was discovered when Blackburn and Szostak showed that Tetrahymena telomeric repeat sequences were sufficient to stabilize a linear plasmid in the budding yeast Saccharomyces cerevisiae (3). This finding pointed to a novel mechanism for telomere replication and set up the conditions for the discovery of the telomerase enzyme. This specialized reverse transcriptase adds telomeric repeat sequences to the 3' ends of chromosomes by reverse-transcribing the template region of its tightly associated RNA moiety (4). In doing so, the telomerase ensures the presence of the same sequence at all telomeres and avoids sequence loss at the ends of chromosomes due to the inability of DNA polymerase to complete the lagging-strand synthesis of DNA ends. In most eukaryotes examined to date, telomeric DNA comprises tandemly repeated G-rich sequences (TG1-3 repeats in yeast and T2AG3 in vertebrates) (5). The G-rich strand forms a 3'-ended single-stranded overhang (G-tail or G-overhang), which allows the recruitment of telomerase (6-8).

Indeed, natural chromosome ends need to be distinguished from damage-induced intrachromosomal DNA double-strand breaks (DSBs) (reviewed in 9-12), which activate a DNA damage response (DDR), including checkpoint-mediated cell cycle arrest and DNA repair/recombination pathways. If cells were to react to the constitutive presence of chromosome ends as if they were DSBs, activation of the checkpoint could lead to perpetual cell cycle arrest, whereas repair/recombination attempts could result in chromosome end-to-end fusions, rearrangements and general genome instability. Hence, it is critical that telomeres escape the DDR and are protected from degradation, recombination, fusion and recognition by the checkpoint machinery (reviewed in 9-12). Nevertheless, some DDR proteins play important roles at telomeres as well. Thus, chromosome ends have evolved strategies to circumvent the harmful effects of the DDR, while at the same time exploiting those DDR activities that are necessary for their maintenance.

In mammalian cells, a complex formed by the TRF1, TRF2, POT1, TIN2, TPP1 and RAP1 proteins with specificity for the telomeric DNA repeats protects the ends of chromosomes from being recognized as DSBs and regulates telomerase-dependent telomere elongation (13). To denote these key roles in both telomere protection and telomere maintenance, this complex is referred to as "shelterin" (reviewed in 14,15). Analogous proteins bound to telomeric DNA exist also in other organisms such as S. pombe and S. cerevisiae.


DSBs induce a DDR that comprises both DNA repair to reverse DNA lesions and checkpoints to inhibit cell cycle progression until DNA lesions have been repaired (reviewed in 16). Two major pathways are devoted to repair a DSB: non-homologous end joining (NHEJ) directly rejoins broken DNA ends with no (or minimal) base pairing at the junction, whereas homologous recombination (HR) utilizes a homologous DNA template to restore the genetic information lost at the break site.

Once a DSB occurs, the highly conserved MRX/MRN complex, composed by the Mre11, Rad50 and Xrs2 (MRX) subunits in budding yeast and of Mre11, Rad50 and Nbs1 (MRN) in both fission yeast and mammals, binds the free ends very rapidly (17) (Figure 1). The Ku70/Ku80 (Ku) heterodimer is also loaded onto DNA ends and, together with MRX, mediates recruitment of downstream NHEJ factors in order to religate the DSB ends (Figure 1). This process requires the DNA ligase activity of the Dnl4-Lif1/XRCC4 heterodimer and the Nej1/XLF protein (reviewed in 18). In budding yeast, Ku binding also promotes NHEJ by protecting the DSB ends from degradation in the G1 phase of the cell cycle (19).

In both yeast and mammals, the presence of MRX/MRN onto DSB ends leads to recruitment/activation of the Tel1/ATM checkpoint kinase (20,21), which signals cell cycle arrest through its kinase activity. While human ATM is a strong activator of the checkpoint triggered by DSBs, yeast Tel1 has a very minor role in checkpoint activation and its signaling activity becomes apparent only after generation of multiple DSBs (22). The MRX/MRN complex is also important, in combination with the Sae2/CtIP protein, for initiating 5'-3' nucleolytic degradation (resection) of the DSB ends to yield 3'-ended single-stranded DNA (ssDNA) tails that initiate HR (Figure 1). In particular, end resection occurs through a biphasic mechanism: first MRX and Sae2 clip 50-100 nucleotides from the 5' DNA ends, and then Exo1 or Sgs1-Top3-Rmi1 and Dna2 process the early intermediate to form extensive ssDNA regions (reviewed in 23,24).

Initiation of DSB processing and subsequent ssDNA generation lead to recruitment and activation of Mec1/ATR (25,26), which binds with its partner Ddc2/ATRIP to ssDNA coated by Replication Protein A (RPA) (Figure 1) (27,28). Full checkpoint activation in response to DSBs also depends on the loading of the 9-1-1 protein complex, which is formed by the Rad17, Mec3 and Ddc1 proteins in S. cerevisiae and is loaded onto DNA by the Rad24-RFC complex (29).

The choice of the pathway for DSB repair is regulated during the cell cycle (Figure 1). While NHEJ is used in the G1 cell cycle phase, HR in haploid cells occurs during S and G2, when DNA replication provides a sister chromatid as a repair template. This cell-cycle specificity depends on cyclin-dependent kinases (Cdks; Cdk1 in S. cerevisiae), which promote resection of the 5' DSB ends to yield 3'-ended ssDNA tails that are necessary to initiate HR and concomitantly inhibit NHEJ (30-32). The Sae2 protein has been shown to be a Cdk1 target in promoting ssDNA generation at DNA ends (33,34), a mechanism that is conserved in the Sae2 vertebrate homolog CtIP. However, as Sae2 only resects a relatively small amount of DNA and other nucleases and helicases are required for efficient DSB resection, Cdk1 likely has additional targets in promoting this event.


Although natural chromosome ends are hidden from detection by the DNA damage recognition machinery, their features (DNA ends with ssDNA overhangs) could be subjected to DNA repair/recombination activities and could elicit a checkpoint response. While resection at DSBs is a prelude to HR, generation of 3'-ended ssDNA is a key step at telomeres because it provides the substrate for telomerase activity. In S. cerevisiae, the G overhang length ranges from 12-14 nucleotides in the G1 cell cycle phase to ~50-100 nucleotides during late S/G2 (35). Lagging-strand replication at the telomere will inevitably lead to a 3' single-stranded overhang due to removal of the terminal RNA primer, whereas the product of leading-strand replication requires further processing to convert blunt ends into 3' overhang structures (Figure 2). At such, it is still unclear whether a 5' resection activity also processes the lagging-strand telomere. The existence of distinct types of end processing at telomeres has been supported by studies that observed (i) chromosomal fusions only among the telomeric products of leading-strand replication in mammalian cells carrying mutant TRF2 (36,37), (ii) much longer G-tails in lagging-strand telomeres than in leading-strand telomeres in human cells lacking active telomerase (38), and (iii) shortening of G-tails by C-strand fill-in synthesis at mammalian lagging telomeres (39).

Notably, the nuclease requirements to resect DSBs and telomeres are similar. In fact, MRX, Sae2, Sgs1, Exo1 and Dna2, which are all required for generation of ssDNA at intrachromosomal DSBs, are also involved in the generation of the G-strand overhangs at telomeres (34,40-42). It has been recently shown that the MRX complex is present only at the leading-strand telomere (43), suggesting that MRX resects the products of leading strand DNA replication, while 3' ssDNA at lagging-strand telomeres could be generated by RNA primer removal and/or MRX-independent processing. In any case, as ssDNA accumulation at DSBs invokes an ATR/Mec1-dependent DDR when it exceeds a certain threshold, telomeres should display an inherent resistance to exonuclease attack to limit the amount of ssDNA at their ends.

Telomeres and DSBs not only have common features but they also share a number of proteins (44), suggesting that, rather than excluding DNA repair/recombination/checkpoint activities, telomeres have evolved to harness the harmful consequences of the DDR. In both yeast and mammals, the checkpoint kinase Tel1/ATM is found at telomeres during S phase in an MRX/MRN-dependent manner and contributes to maintain telomere length (45-47). In S. cerevisiae, both Tel1 and MRX are required for recruitment of the telomerase subunits Est1 and Est2 specifically to short telomeres (48-52), which are preferentially elongated by telomerase (53). These findings suggest that MRX binding is the critical step that marks telomeres for elongation by telomerase.

The Ku heterodimer, which is necessary for NHEJ, is also involved in maintaining telomere length in S. cerevisiae, S. pombe and humans, and this function appears to be distinct from Ku function in NHEJ (reviewed in 54). Budding yeast Ku performs different functions at telomeres: i) it is important for recruiting telomerase to telomeres by binding to a stem-loop portion of TLC1 RNA (55-59), and ii) it protects telomeres from nuclease activities (60-63).


The shelterin complex plays an important role in maintaining telomere identity. In mammals, this complex is composed of the six core proteins TRF1, TRF2 (telomeric repeat binding factors 1 and 2), TIN2 (TRF1-interacting protein 2), POT1 (protection of telomeres 1), TPP1 (TIN2-POT1 organizing protein) and RAP1 (repressor/activator protein 1) (Figure 3). TRF1 and TRF2 are related to each other, as they both harbor a C-terminal Myb domain of the homeodomain subfamily, but differ at their N terminus that is acidic in TRF1 while it is basic in TRF2 (64-72). TRF1 and TRF2 bind the TTAGGG sequences in double-stranded DNA and recruit TIN2 and RAP1, respectively (73,74). The single-stranded G-overhang is bound by the POT1-TPP1 heterodimer. Both POT1 and TPP1 proteins contain OB (oligonucleotide/oligosaccharide binding)-fold domains (75-79). TPP1 also interacts with TIN2, and therefore these two proteins are postulated to bridge the shelterin components that bind double-stranded and single-stranded telomeric DNA (78,80,81). The TPP1 binding site in TIN2 appears distinct from its TRF2 binding site (82), raising the possibility that TIN2 might switch between TRF1/TRF2-bound and TPP1/POT1-bound states. In addition, the OB-fold domain at the N-terminus of TPP1 interacts with telomerase, suggesting a role for TPP1 in telomerase recruitment to chromosome ends (78,83). Finally, TRF2 forms a complex with RAP1, and this association is essential for RAP1 binding to telomeres (84). RAP1 contains three different domains: a Myb-like domain that may have a role in protein-protein interactions, an N-terminal BRCT motif and a C-terminal domain involved in TRF2 binding (74,85).

Shelterin-related proteins are also found at telomeres in other eukaryotes. Fission yeast telomeres are bound by a TPP1/POT1-like dimer, Tpz1/Pot1, and by a TRF-like protein, Taz1, which binds to Rap1 (Figure 3) (75,86,87). As in mammals, Taz1 recruits Rap1 (88,89), which interacts with Pot1 via a Poz1-Tpz1 bridge, thus establishing a link between the duplex and single-stranded telomeric DNA binding factors (87). Budding yeast telomeres appear to have diverged in protein composition (Figure 3). The only shelterin component structurally conserved in budding yeast is Rap1 (90-92), which contains two Myb domains with little homology to those found in TRFs proteins and interacts with the Rif1 and Rif2 proteins via its C-terminal domain (93-95). Unlike mammalian and fission yeast Rap1 that lack DNA binding activity, budding yeast Rap1 binds directly to telomeric double stranded DNA repeats.


The shelterin complex has a key role in allowing telomeres to escape the potential harmful effects of checkpoint activation, NHEJ and HR. Inhibition or deletion of individual shelterin components has revealed that this complex is required to avoid activation of the checkpoint kinases ATM and ATR. In fact, deletion of TRF2 in mouse embryonic fibroblasts or its inhibition by a dominant negative allele in human cells result in ATM-dependent DNA damage checkpoint activation (84,96,97). ATM activation under these conditions leads to recruitment of 53BP1, MDC1 and phosphorylated histone H2AX at the exposed telomeres, forming the so-called telomere dysfunction-induced foci (TIFs) (98,99). These events culminate in activation of the cell cycle regulator p53, leading to either cell cycle arrest or cell death. On the other hand, repression of ATR at telomeres does not require TRF2, but depends on POT1 (97). Conditional deletion of POT1 in mouse embryonic fibroblasts or POT1 downregulation in human cells elicit an ATR-dependent DNA damage response, as evidenced by formation of TIFs and phosphorylation of the Chk1 and Chk2 checkpoint kinases and of histone H2AX (100-103). Formation of TIFs is diminished when ATR-dependent checkpoint signalling is prevented, whereas it is unaltered in ATM-deficient cells, implicating POT1 in the repression of ATR. Thus, the two main checkpoint signalling proteins ATM and ATR appear to be independently inhibited by distinct shelterin components in mammalian cells (Figure 4A).

TRF2 and POT1 are also required to block DNA repair and recombination activities at mammalian telomeres (Figure 4A). Conditional TRF2 deletion in mouse embryonic fibroblasts or expression of a dominant negative allele in human cells result in DNA ligase IV-dependent telomeric fusions (84,104-106). By contrast, POT1 plays a minor role in NHEJ repression, as its knockdown leads to a marginal increase in telomere fusions (101,107,108). Telomere fusion events upon loss of TRF2 are restricted to the G1 phase of the cell cycle (109), whereas both TRF2 and POT1 contribute to inhibit NHEJ in G2 (101,110). Furthermore, TRF2, POT1 and RAP1 inhibit HR at telomeres (110-113). Interestingly, Ku is redundant with either TRF2 or POT1 in its ability to prevent HR at telomeres (112,114). Thus, Ku plays a dual role at telomeres: it initiates detrimental telomeric fusions as an integral part of the NHEJ machinery, but at the same time it protects telomeres from HR.

In S. pombe, like in mammals, the TRF-like protein Taz1 represses both NHEJ and HR at telomeres (115,116), whereas Pot1 blocks telomere nucleolytic degradation (117). The fusion events in Taz1-lacking cells appear to require the canonical NHEJ machinery. Protection from NHEJ-mediated telomeric fusions is also lost in the absence of Rap1 (118), whose recruitment at telomeres requires Taz1.

In S. cerevisiae, the Rap1 and Rif2 proteins inhibit both NHEJ and nucleolytic processing at telomeres (Figure 4B) (61,63,119,120). Generation of telomeric ssDNA in cells defective for Rif2 or Rap1 requires the MRX complex (61,62), suggesting that Rap1 and Rif2 prevent MRX action at telomeric ends. Rap1 and Rif2 inhibitory action on telomere processing is partially redundant with that of Ku, whose lack causes Exo1-dependent accumulation of telomeric ssDNA, as well as checkpoint-mediated cell cycle arrest at high temperatures (60,121-123). On the other hand, inactivation of Rap1 or Rif2 does not elicit a checkpoint response, suggesting that either the accumulated telomeric ssDNA is insufficient for RPA binding and Mec1 activation or that this ssDNA is still covered by Cdc13 (see below), which can inhibit the association of the checkpoint kinase Mec1 to telomeres (124).

Unlike Rif2 and Rap1, Rif1 is not involved in preventing telomeric fusions by NHEJ (120) and plays a very minor role in protecting telomeres from degradation (61). Instead, Rif1 is functionally connected with the protein complex CST (Figure 4B) (125), which is formed by Cdc13, Stn1 and Ten1, and binds to telomeric ssDNA overhangs (reviewed in 126). The three CST subunits, each of which contains one or more OB-fold domains, bear a structural resemblance to the three components of the RPA complex (127), suggesting that CST is a telomere-specific version of RPA. CST is required for telomere integrity, as loss of Cdc13, Stn1 or Ten1 function results in telomere degradation and checkpoint activation (128-133). Interestingly, deletion of RIF1 in cst mutants increases generation of telomeric ssDNA that causes activation of the DNA damage checkpoint (125), indicating that Rif1 plays a unique role in supporting the capping function of CST. Whether functional connections between shelterin and CST exist also in other organisms remains to be determined.


How TRF2 inhibits ATM activation at telomeres is unknown. One possibility is that TRF2 capping function depends on its ability to determine a proper terminal DNA end-structure. In mammals, the single-stranded telomeric 3' overhang invades the duplex part of the telomere, forming a structure called t-loop (134). Based on the observation that purified TRF2 has the ability to generate t-loop-like structures in vitro, TRF2 has been proposed to promote t-loop formation (135,136). Thus, as t-loops sequester the telomeric ends within a base-paired structure, TRF2-mediated t-loop formation would provide a mechanism to hide telomeres from NHEJ and ATM activation. Alternatively, or in addition, TRF2 might directly inhibit the ATM kinase, as TRF2 overexpression results in downregulation of ATM activation in response to DSBs at nontelomeric sites (137). Notably, t-loops are unlikely to occur at S. cerevisiae telomeres that are short (300 bp) and have short G-strand overhangs for most of the cell cycle. However, given that the ATM yeast ortholog, Tel1, has a very minor role in eliciting a DSB-induced checkpoint compared to Mec1 (22), the advantages that might be offered by t-loops are minimal in S. cerevisiae.

In the t-loop structure, the displaced D-loop contains a short segment of ssDNA that might activate ATR. Thus, t-loop formation does not explain how telomeres block activation of ATR, which is triggered by generation of ssDNA covered by RPA. ATR repression at telomeres does not require TRF2, but it depends on POT1 and TPP1. Based on the finding that POT1 is present on the telomeric ssDNA overhangs, it has been proposed that POT1/TTP1 prevents the binding of RPA to these overhangs (97). This competition may also play an important role in the repression of HR, which requires binding of RPA and other DNA recombination proteins to ssDNA.

The S. cerevisiae telomeric single-stranded overhangs are bound by Cdc13 in association with the RPA-like proteins Stn1 and Ten1 (126,127). It has been shown that Cdc13 binding to the single-stranded telomeric G tails attenuates Mec1 association with these DNA ends (124). Thus, as proposed for ATR inhibition by POT1, Cdc13 might prevent Mec1 activation by blocking RPA binding to telomeric ssDNA. In any case, it is well known that ssDNA accumulation at DSBs invokes an ATR/Mec1-dependent DNA damage response when it exceeds a certain threshold (138,139). Thus, one way to ensure that telomeres do not activate the DNA damage response would be to reduce the amount of ssDNA by resisting to nuclease attack. In S. cerevisiae, Rap1 and Rif2 have been found to limit MRX-dependent generation of telomeric ssDNA (61). The finding that MRX association at telomeres is enhanced in Rif2- or Rap1-defective mutants (61,140) suggests that Rap1 and Rif2 directly or indirectly inhibit MRX recruitment onto telomeric ends.

As discussed above, the Rif1 component of the budding yeast shelterin-like complex has a unique function in supporting the capping activity of the CST complex (125). CST-like complexes exist also in S. pombe, plants and mammals (141-144). Indeed, the yeast CST complex genetically and physically interacts with the polymerase alpha-primase complex (145,146) that is essential for lagging strand replication. Furthermore, the human CST-like complex increases polymerase alpha-primase processivity (147,148). As also Rif1 was found to functionally interact with the polymerase alpha-primase complex (125), one possibility is that Rif1 might participate together with CST in coupling telomerase-dependent telomere elongation to the priming of telomeric C strand synthesis.


Shelterin has an inhibitory effect on telomere length. Although telomeres vary considerably in length between organisms, the average length is kept within a narrow species-specific range, indicating that the telomerase enzyme is regulated in cis at individual telomeres. It was proposed that telomere length regulation is achieved through a negative feedback loop, where the telomeric DNA is bound by an inhibitor of telomerase in an amount proportional to telomere length (149). According to this model, elongation of a telomere by telomerase leads to an increased amount of the inhibitor, thus decreasing the probability of further elongation of this telomere by telomerase.

Some data in both yeast and mammals indicate that the shelterin proteins can be used to "size" the length of a telomere. In S. cerevisiae, the Rap1 protein negatively regulates telomere length (91,149), and the Rap1-binding proteins Rif1 and Rif2 contribute to this negative regulation (150). In fission yeast, loss of Taz1 results in uncontrolled telomere elongation (86). In humans, TRF1 or TRF2 overexpression causes telomere shortening, whereas a dominant negative form of TRF1 that removes the endogenous TRF1 from telomeres induces progressive telomere elongation (151,152). Furthermore, reduction of TIN2 or Rap1 protein levels also leads to telomere lengthening (78,81,153,154). POT1 is thought to have a key function in telomerase inhibition, because it is the only shelterin component that binds the telomeric single-stranded overhangs, which are necessary for telomerase action. In fact, extensive telomere elongation is observed when either a mutant form of POT1 lacking the DNA-binding domain is overexpressed or POT1 loading at telomeres is diminished (78,155). Because in vitro association of recombinant human POT1 with telomere oligonucleotide ends inhibits telomerase binding (156,157), it has been proposed that telomerase competes with POT1 for binding to the telomeric 3' single-stranded G-overhangs. Based on this model, depletion of the other shelterin components may lead to telomere overelongation, because their removal decreases POT1 recruitment to telomeres, thereby rendering the chromosome ends accessible to telomerase. On the other hand, POT1 might also promote telomerase action, especially when it is bound to TPP1 that is known to physically interact with telomerase (79,83).

The molecular details of shelterin-mediated regulation of telomerase activity are still largely unknown. Some insights into this topic are provided by data in S. cerevisiae, where telomerase binds and preferentially elongates short telomeres (53). In current models, telomerase is targeted to short telomeres by the Tel1 checkpoint kinase, which has been shown to be essential for the increased association of telomerase to short telomeres during late S/G2 (48-52). The MRX complex, once bound to short telomeres, enhances the localization of Tel1, which in turn promotes telomerase recruitment and activity possibly through phosphorylation events. Using a system that induces a specific chromosome break adjacent to telomere repeats, it has been shown that Rif2 inhibits MRX-dependent loading of Tel1 onto telomeric ends (140). Furthermore, Rif2 directly binds to the Xrs2 C-terminus, which has been implicated in Tel1 binding, and inhibits Tel1-Xrs2 interaction in vitro. These data support a model in which Rif2 counteracts telomerase action by competing with Tel1 for binding to the MRX complex. Indeed, Tel1 no longer binds preferentially to short telomeres in cells lacking Rif2, suggesting that reduced Rif2 content is a signal that marks short telomeres for preferential Tel1 binding and telomerase-mediated elongation (158).


Considerable progress has been made in unraveling the molecular mechanism that distinguish telomeres from DSBs. Work carried out in different experimental systems are converging to a scenario where protection of telomeric ends depends on a bulk of proteins (shelterin) with specificity to telomeric DNA. These proteins allow chromosome ends to escape the potential harmful effects of checkpoint activation, chromosome end-to-end fusions or sequences exchanges that involve two telomeres or a telomere and another part of the genome.

Notably, mounting evidence in recent years, suggests a potential role of shelterin components in cancer and aging (reviewed in 159). Studies using mice that were genetically modified for various shelterin components suggest a role for these proteins in cancer susceptibility and aging-related pathologies even in the presence of normal telomerase activity (reviewed in 160). Furthermore, expression of TRF1, TRF2, TIN2 and POT1 is altered in some human tumors and mutations in TIN2, TRF2 and TRF1 have been linked to some cases of Dyskeratosis congenita and aplastic anemia (reviewed in 160). Thus, a more thorough understanding of the molecular mechanisms that allows these proteins to maintain telomere identity is important to gain a full characterization of telomere regulation and to devise strategies for mitigating the impact of telomere dysfunction on cancer, aging and disease.


Research in Longhese's lab is funded by grants from Associazione Italiana per la Ricerca sul Cancro (grant IG5636) and Cofinanziamento 2008 MIUR/Universita di Milano-Bicocca. SA was supported by EU contract PITN-GA-2008-215148 Image DDR. MM was supported by a fellowship from Fondazione Confalonieri. We thank Giovanna Lucchini and Michela Clerici for their critical reading and input. We apologize to all authors whose publications have not been cited due to space limitation.


1. Muller HJ: The remaking of chromosomes. Collect Net 8, 182-195 (1938)

2. McClintock B: The behaviour in successive nuclear divisions of a chromosome broken at meiosis. Genetics 25, 405-416 (1939)

3. Szostak JW, and Blackburn EH: Cloning yeast telomeres on linear plasmid vectors. Cell 29, 245-255 (1982)

4. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413 (1985)

5. Gomes NM, Shay JW and Wright WE: Telomere biology in Metazoa. FEBS Lett 584, 3741-3751 (2010)

6. Henderson ER and Blackburn EH: An overhanging 3' terminus is a conserved feature of telomeres. Mol Cell Biol 9, 345-348 (1989)

7. Makarov VL, Hirose Y, and Langmore JP: Long G tails at both ends of human chromosomes suggest a C-strand degradation mechanism for telomere shortening. Cell 88, 657-666. (1997)

8. McElligott R and Wellinger RJ: The terminal DNA structure of mammalian chromosomes. EMBO J 16, 3705-3714 (1997)

9. Longhese MP: DNA damage response at functional and dysfunctional telomeres. Genes Dev 22, 125-140 (2008)

10. Lydall D: Taming the tiger by the tail: modulation of DNA damage responses by telomeres. EMBO J 28, 2174-2187 (2009)

11. Jain D and Cooper JP: Telomeric strategies: means to an end. Annu Rev Genet 44, 243-269 (2010)

12. O'Sullivan RJ and Karlseder J: Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 11, 171-181 (2010)

13. Liu D, O'Connor MS, Qin J, and Songyang Z: Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 279, 51338-51342 (2004)

14. de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19, 2100-2110 (2005)

15. Palm W and de Lange T: How shelterin protects mammalian telomeres. Annu Rev Genet 42, 301-334 (2008)

16. Ciccia A and Elledge SJ: The DNA damage response: making it safe to play with knives. Mol Cell 40, 179-204 (2010)

17. Lisby M, Barlow JH, Burgess RC, and Rothstein R: Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins. Cell 118, 699-713 (2004)

18. Daley JM, Palmbos PL, Wu D, and Wilson TE: Nonhomologous end joining in yeast. Annu Rev Genet 39, 431-451 (2005)

19. Clerici M, Mantiero D, Guerini I, Lucchini G, and Longhese MP: The Yku70-Yku80 complex contributes to regulate double-strand break processing and checkpoint activation during the cell cycle. EMBO Rep 9, 810-818 (2008)

20. Nakada D, Matsumoto K, and Sugimoto K: ATM-related Tel1 associates with double-strand breaks through an Xrs2-dependent mechanism. Genes Dev 16, 1957-1962 (2003)

21. Falck J, Coates J, and Jackson SP: Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605-611 (2005)

22. Mantiero D, Clerici M, Lucchini G, and Longhese MP: Dual role for Saccharomyces cerevisiae Tel1 in the checkpoint response to double-strand breaks. EMBO Rep 8, 380-387 (2007)

23. Longhese MP, Bonetti D, Manfrini N, and Clerici M: Mechanisms and regulation of DNA end resection. EMBO J 29, 2864-2874 (2010)

24. Mimitou EP and Symington LS: DNA end resection-unraveling the tail. DNA Repair 10, 344-348 (2011)

25. Zou L and Elledge SJ: Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300, 1542-1548 (2003)

26. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, and Jackson SP: ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8, 37-45 (2006)

27. Paciotti V, Clerici M, Lucchini G, and Longhese MP: The checkpoint protein Ddc2, functionally related to S. pombe Rad26, interacts with Mec1 and is regulated by Mec1-dependent phosphorylation in budding yeast. Genes Dev 14, 2046-2059 (2000)

28. Cortez D, Guntuku S, Qin J, and Elledge SJ: ATR and ATRIP: partners in checkpoint signaling. Science 294, 1713-1716 (2001)

29. Majka J, Niedziela-Majka A, and Burgers PM: The checkpoint clamp activates Mec1 kinase during initiation of the DNA damage checkpoint. Mol Cell 24, 891-901 (2006)

30. Aylon Y, Liefshitz B, and Kupiec M: The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle. EMBO J 23, 4868-4875 (2004)

31. Ira G, Pellicioli A, Balijja A, Wang X, Fiorani S, Carotenuto W, Liberi G, Bressan D, Wan L, Hollingsworth NM, Haber JE, and Foiani M: DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1. Nature 431, 1011-1017 (2004)

32. Zhang Y, Shim EY, Davis M, and Lee SE: Regulation of repair choice: Cdk1 suppresses recruitment of end joining factors at DNA breaks. DNA Repair 8, 1235-1241 (2009)

33. Huertas P, Cortés-Ledesma F, Sartori AA, Aguilera A, and Jackson SP: CDK targets Sae2 to control DNA-end resection and homologous recombination. Nature 455, 689-692 (2008)

34. Bonetti D, Martina M, Clerici M, Lucchini G, and Longhese MP: Multiple pathways regulate 3' overhang generation at S. cerevisiae telomeres. Mol Cell 35, 70-81 (2009)

35. Wellinger RJ, Wolf AJ, and Zakian VA: Saccharomyces telomeres acquire single-strand TG1-3 tails late in S phase. Cell 72, 51-60 (1993)

36. Bailey SM, Cornforth MN, Kurimasa A, Chen DJ, and Goodwin EH: Strand-specific postreplicative processing of mammalian telomeres. Science 293, 2462-2465 (2001)

37. Deng Y, Guo X, Ferguson DO, and Chang S: Multiple roles for MRE11 at uncapped telomeres. Nature 460, 914-918 (2009)

38. Chai W, Du Q, Shay JW, and Wright WE: Human telomeres have different overhang sizes at leading versus lagging strands. Mol Cell 21, 427-435 (2006)

39. Dai X, Huang C, Bhusari A, Sampathi S, Schubert K, and Chai W: Molecular steps of G-overhang generation at human telomeres and its function in chromosome end protection. EMBO J 29, 2788-2801 (2010)

40. Diede SJ and Gottschling DE: Exonuclease activity is required for sequence addition and Cdc13p loading at a de novo telomere. Curr Biol 11, 1336-1340 (2001)

41. Larrivée M, LeBel C, and Wellinger R: The generation of proper constitutive G-tails on yeast telomeres is dependent on the MRX complex. Genes Dev 18, 1391-1396 (2004)

42. Chai W, Sfeir AJ, Hoshiyama H, Shay JW, and Wright WE: The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-overhangs at human telomeres. EMBO Rep 7, 225-230 (2006)

43. Faure V, Coulon S, Hardy J, and Geli V: Cdc13 and telomerase bind through different mechanisms at the lagging- and leading-strand telomeres. Mol Cell 38, 842-852 (2010)

44. Longhese MP, Paciotti V, Neecke H, and Lucchini G: Checkpoint proteins influence telomeric silencing and length maintenance in budding yeast. Genetics 155, 1577-1591 (2000)

45. Ritchie KB and Petes TD: The Mre11p/Rad50p/Xrs2p complex and the Tel1p function in a single pathway for telomere maintenance in yeast. Genetics 155, 475-479 (2000)

46. Verdun RE, Crabbe L, Haggblom C, and Karlseder J: Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol Cell 20, 551-561 (2005)

47. Wu Y, Xiao S, and Zhu XD: MRE11-RAD50-NBS1 and ATM function as co-mediators of TRF1 in telomere length control. Nat Struct Mol Biol 14, 832-840 (2007)

48. Tsukamoto Y, Taggart AK, and Zakian VA: The role of the Mre11-Rad50-Xrs2 complex in telomerase- mediated lengthening of Saccharomyces cerevisiae telomeres. Curr Biol 11, 1328-1335 (2001)

49. Goudsouzian LK, Tuzon CT, and Zakian VA: S. cerevisiae Tel1p and Mre11p are required for normal levels of Est1p and Est2p telomere association. Mol Cell 24, 603-610 (2006)

50. Bianchi A and Shore D: Increased association of telomerase with short telomeres in yeast. Genes Dev 21, 1726-1730 (2007)

51. Hector RE, Shtofman RL, Ray A, Chen BR, Nyun T, Berkner KL, and Runge KW: Tel1p preferentially associates with short telomeres to stimulate their elongation. Mol Cell 27, 851-858 (2007)

52. Sabourin M, Tuzon CT, and Zakian VA: Telomerase and Tel1p preferentially associate with short telomeres in S. cerevisiae. Mol Cell 27, 550-561 (2007)

53. Teixeira MT, Arneric M, Sperisen P, and Lingner J: Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell 117, 323-335 (2004)

54. Fisher TS and Zakian VA: Ku: a multifunctional protein involved in telomere maintenance. DNA Repair 4, 1215-1226 (2005)

55. Peterson SE, Stellwagen AE, Diede SJ, Singer MS, Haimberger ZW, Johnson CO, Tzoneva M, and Gottschling DE: The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku. Nat Genet 27, 64-67 (2001)

56. Chai W, Ford LP, Lenertz L, Wright WE, and Shay JW: Human Ku70/80 associates physically with telomerase through interaction with hTERT. J Biol Chem 277, 47242-47247 (2002)

57. Stellwagen AE, Haimberger ZW, Veatch JR, and Gottschling DE: Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends. Genes Dev 17, 2384-2395 (2003)

58. Fisher TS, Taggart AK, and Zakian VA: Cell cycle-dependent regulation of yeast telomerase by Ku. Nat Struct Mol Biol 11, 1198-1205 (2004)

59. Chan A, Boulé JB, and Zakian VA: Two pathways recruit telomerase to Saccharomyces cerevisiae telomeres. PLoS Genet 4, e1000236 (2008)

60. Maringele L and Lydall D: EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70delta mutants. Genes Dev 16, 1919-1933 (2002)

61. Bonetti D, Clerici M, Anbalagan S, Martina M, Lucchini G, and Longhese MP: Shelterin-like proteins and Yku inhibit nucleolytic processing of Saccharomyces cerevisiae telomeres. PLoS Genetics 6, e1000966 (2010)

62. Bonetti D, Clerici M, Manfrini N, Lucchini G, and Longhese MP: The MRX complex plays multiple functions in resection of Yku- and Rif2-protected DNA ends. PLoS One 5, e14142 (2010)

63. Vodenicharov MD, Laterreur N, and Wellinger RJ: Telomere capping in non-dividing yeast cells requires Yku and Rap1. EMBO J 29, 3007-3019 (2010)

64. Zhong Z, Shiue L, Kaplan S, and de Lange T: A mammalian factor that binds telomeric TTAGGG repeats in vitro. Mol Cell Biol 12, 4834-4843 (1992)

65. Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, and Gilson E: Telomeric localization of TRF2, a novel human telobox protein. Nat Genet 17, 236-239 (1997)

66. Broccoli D, Smogorzewska A, Chong L, and de Lange T: Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 17, 231-235 (1997)

67. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P, and de Lange T: A human telomeric protein. Science 270, 1663-1667 (1995)

68. Bianchi A, Stansel RM, Fairall L, Griffith JD, Rhodes D, and de Lange T: TRF1 binds a bipartite telomeric site with extreme spatial flexibility. EMBO J 18, 5735-5744 (1999)

69. Fairall L, Chapman L, Moss H, de Lange T, and Rhodes D: Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2. Mol Cell 8, 351-361 (2001)

70. Court R, Chapman L, Fairall L, and Rhodes D: How the human telomeric proteins TRF1 and TRF2 recognize telomeric DNA: a view from high-resolution crystal structures. EMBO Rep. 6, 39-45 (2005)

71. Hanaoka S, Nagadoi A, and Nishimura Y: Comparison between TRF2 and TRF1 of their telomeric DNA-bound structures and DNA-binding activities. Protein Sci 14, 119-130 (2005)

72. Chen Y, Yang Y, van Overbeek M, Donigian JR, Baciu P, de Lange T, and Lei M: A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. Science 319, 1092-1096 (2008)

73. Kim SH, Kaminker P, and Campisi J: TIN2, a new regulator of telomere length in human cells. Nat Genet 23, 405-412 (1999)

74. Li B, Oestreich S, and de Lange T: Identification of human Rap1: implications for telomere evolution. Cell 101, 471-483 (2000)

75. Baumann P and Cech TR: Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292, 1171-1175 (2001)

76. Lei M, Podell ER, and Cech TR: Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat Struct Mol Biol 11, 1223-1229 (2004)

77. Loayza D, Parsons H, Donigian J, Hoke K, and de Lange T: DNA binding features of human POT1: a nonamer 5'-TAGGGTTAG-3' minimal binding site, sequence specificity, and internal binding to multimeric sites. J Biol Chem 279, 13241-13248 (2004)

78. Ye JZ, Hockemeyer D, Krutchinsky AN, Loayza D, Hooper SM, Chait BT, and de Lange T: POT1-interacting protein PIP1: A telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev 18, 1649-1654 (2004)

79. Wang F, Podell ER, Zaug AJ, Yang Y, Baciu P, Cech TR, and Lei M: The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 445, 506-510 (2007)

80. Houghtaling BR, Cuttonaro L, Chang W, and Smith S: A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol 14, 1621-1631 (2004)

81. Kim SH, Beausejour C, Davalos AR, Kaminker P, Heo SJ, and Campisi J: TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem 279, 43799-43804 (2004)

82. O'Connor MS, Safari A, Xin H, Liu D, and Songyang Z: A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc Natl Acad Sci 103, 11874-11879 (2006)

83. Xin H, Liu D, Wan M, Safari A, Kim H, Sun W, O'Connor MS, and Songyang Z: TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 445, 559-562 (2007)

84. Celli GB and de Lange T: DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol 7, 712-718 (2005)

85. Hanaoka S, Nagadoi A, Yoshimura S, Aimoto S, Li B, de Lange T, and Nishimura Y: NMR structure of the hRap1 Myb motif reveals a canonical three-helix bundle lacking the positive surface charge typical of Myb DNA-binding domains. J Mol Biol 312, 167-175 (2001)

86. Cooper JP, Nimmo ER, Allshire RC, and Cech TR: Regulation of telomere length and function by a Myb-domain protein in fission yeast. Nature 385, 744-747 (1997)

87. Miyoshi T, Kanoh J, Saito M, and Ishikawa F: Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length. Science 320, 1341-1344 (2008)

88. Chikashige Y and Hiraoka Y: Telomere binding of the Rap1 protein is required for meiosis in fission yeast. Curr Biol 11, 1618-1623 (2001)

89. Kanoh J and Ishikawa F: spRap1 and spRif1, recruited to telomeres by Taz1, are essential for telomere function in fission yeast. Curr Biol 11, 1624-1630 (2001)

90. Longtine MS, Wilson NM, Petracek ME, and Berman J: A yeast telomere binding activity binds to two related telomere sequence motifs and is indistinguishable from RAP1. Curr Genet 16, 225-239 (1989)

91. Conrad MN, Wright JH, Wolf AJ, and Zakian VA: RAP1 protein interacts with yeast telomeres in vivo: overproduction alters telomere structure and decreases chromosome stability. Cell 63, 739-750 (1990)

92. Lustig AJ, Kurtz S, and Shore D: Involvement of the silencer and UAS binding protein RAP1 in regulation of telomere length. Science 250, 549-553 (1990)

93. Hardy CF, Sussel L, and Shore D: A Rap1-interacting protein involved in silencing and telomere length regulation. Genes Dev 6, 801-814 (1992)

94. Kyrion G, Boakye KA, and Lustig AJ: C-terminal truncation of RAP1 results in the deregulation of telomere size, stability, and function in Saccharomyces cerevisiae. Mol Cell Biol 12, 5159-5173 (1992)

95. Wotton D and Shore D: A novel Rap1p-interacting factor, Rif2p, cooperates with Rif1p to regulate telomere length in Saccharomyces cerevisiae. Genes Dev 11, 748-760 (1997)

96. Karlseder J, Broccoli D, Dai Y, Hardy S, and de Lange T: p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325 (1999)

97. Lazzerini Denchi E and de Lange T: Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448, 1068-1071 (2007)

98. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, and Jackson SP: A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198 (2003)

99. Takai H, Smogorzewska A, and de Lange T: DNA damage foci at dysfunctional telomeres. Curr Biol 13, 1549-1556 (2003)

100. Churikov D, Wei C, and Price CM: Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection. Mol Cell Biol 26, 6971-6982 (2006)

101. Hockemeyer D, Daniels JP, Takai H, and de Lange T: Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell 126, 63-77 (2006)

102. Hockemeyer D, Palm W, Else T, Daniels JP, Takai KK, Ye JZ, Keegan CE, de Lange T, and Hammer GD: Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat Struct Mol Biol 14, 754-761 (2007)

103. Guo X, Deng Y, Lin Y, Cosme-Blanco W, Chan S, He H, Yuan G, Brown EJ, and Chang S: Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J 26, 4709-4719 (2007)

104. van Steensel B, Smogorzewska A, and de Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401-413 (1998)

105. Smogorzewska A, Karlseder J, Holtgreve-Grez H, Jauch A, and de Lange T: DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr Biol 12, 1635-1644 (2002)

106. Bae NS and Baumann P: A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol Cell 26, 323-334 (2007)

107. Hockemeyer D, Sfeir AJ, Shay JW, Wright WE, and de Lange T: POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J 20, 2667-2678 (2005)

108. Veldman T, Etheridge KT, and Counter CM: Loss of hPot1 function leads to telomere instability and a cut-like phenotype. Curr Biol 14, 2264-2270 (2004)

109. Konishi A and de Lange T: Cell cycle control of telomere protection and NHEJ revealed by a ts mutation in the DNA-binding domain of TRF2. Genes Dev 22, 1221-1230 (2008)

110. Wu L, Multani AS, He H, Cosme-Blanco W, Deng Y, Deng JM, Bachilo O, Pathak S, Tahara H, Bailey SM, Deng Y, Behringer RR, and Chang S: Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126, 49-62 (2006)

111. Wang RC, Smogorzewska A, and de Lange T: Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119, 355-368. (2004)

112. Celli GB, Lazzerini Denchi E, and de Lange T: Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat Cell Biol 8, 885-890 (2006)

113. Sfeir A, Kabir S, van Overbeek M, Celli GB, and de Lange T: Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 327, 1657-1661 (2010)

114. Palm W, Hockemeyer D, Kibe T, and de Lange T: Functional dissection of human and mouse POT1 proteins. Mol Cell Biol 29, 471-82 (2009)

115. Ferreira MG and Cooper JP: The fission yeast Taz1 protein protects chromosomes from Ku-dependent end-to-end fusions. Mol Cell 7, 55-63 (2001)

116. Subramanian L, Moser BA, and Nakamura TM: Recombination-based telomere maintenance is dependent on Tel1-MRN and Rap1 and inhibited by telomerase, Taz1, and Ku in fission yeast. Mol Cell Biol 28, 1443-1455 (2008)

117. Pitt CW and Cooper JP: Pot1 inactivation leads to rampant telomere resection and loss in one cell cycle. Nucleic Acids Res 38, 6968-6975 (2010)

118. Miller KM, Ferreira MG, and Cooper JP: Taz1, Rap1 and Rif1 act both interdependently and independently to maintain telomeres. EMBO J 24, 3128-3135 (2005)

119. Pardo B and Marcand S: Rap1 prevents telomere fusions by nonhomologous end joining. EMBO J 24, 3117-3127 (2005)

120. Marcand S, Pardo B, Gratias A, Cahun S, and Callebaut I: Multiple pathways inhibit NHEJ at telomeres. Genes Dev 22, 1153-1158 (2008)

121. Gravel S, Larrivée M, Labrecque P, and Wellinger RJ: Yeast Ku as a regulator of chromosomal DNA end structure. Science 280, 741-744 (1998)

122. Polotnianka RM, Li J, and Lustig AJ: The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities. Curr Biol 8, 831-834 (1998)

123. Bertuch AA and Lundblad V: EXO1 contributes to telomere maintenance in both telomerase-proficient and telomerase-deficient Saccharomyces cerevisiae. Genetics 166, 1651-1659 (2004)

124. Hirano Y and Sugimoto K: Cdc13 telomere capping decreases Mec1 association but does not affect Tel1 association with DNA ends. Mol Biol Cell 18, 2026-2036 (2007)

125. Anbalagan S, Bonetti D, Lucchini G, and Longhese MP: Rif1 supports the function of the CST complex in yeast telomere capping. PLoS Genet 7, e1002024 (2011)

126. Giraud-Panis MJ, Teixeira MT, Géli V, and Gilson E: CST meets shelterin to keep telomeres in check. Mol Cell 39, 665-676 (2010)

127. Gao H, Cervantes RB, Mandell EK, Otero JH, and Lundblad V: RPA-like proteins mediate yeast telomere function. Nat Struct Mol Biol 14, 208-214 (2007)

128. Garvik B, Carson M, and Hartwell LL: Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint. Mol Cell Biol 15, 6128-6138 (1995)

129. Lydall D and Weinert T: Yeast checkpoint genes in DNA damage processing: implications for repair and arrest. Science 270, 1488-1491 (1995)

130. Grandin N, Reed SI, and Charbonneau M: Stn1, a new Saccharomyces cerevisiae protein, is implicated in telomere size regulation in association with Cdc13. Genes Dev 11, 512-527 (1997)

131. Grandin N, Damon C, and Charbonneau M: Ten1 functions in telomere end protection and length regulation in association with Stn1 and Cdc13. EMBO J 20, 1173-1183 (2001)

132. Vodenicharov MD and Wellinger RJ: DNA degradation at unprotected telomeres in yeast is regulated by the CDK1 (Cdc28/Clb) cell-cycle kinase. Mol Cell 24, 127-137 (2006)

133. Xu L, Petreaca RC, Gasparyan HJ, Vu S, and Nugent CI: TEN1 is essential for CDC13-mediated telomere capping. Genetics 183, 793-810 (2009)

134. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, and de Lange T: Mammalian telomeres end in a large duplex loop. Cell 97, 503-514 (1999)

135. Stansel RM, de Lange T, and Griffith JD: T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang. EMBO J 20, 5532-5540 (2001)

136. Poulet A, Buisson R, Faivre-Moskalenko C, Koelblen M, Amiard S, Montel F, Cuesta-Lopez S, Bornet O, Guerlesquin F, Godet T, Moukhtar J, Argoul F, Déclais AC, Lilley DM, Ip SC, West SC, Gilson E, and Giraud-Panis MJ: TRF2 promotes, remodels and protects telomeric Holliday junctions. EMBO J 28, 641-651 (2009)

137. Karlseder J, Hoke K, Mirzoeva OK, Bakkenist C, Kastan MB, Petrini JH, and de Lange T: The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol 2, E240 (2004)

138. Pellicioli A, Lee SE, Lucca C, Foiani M, and Haber JE: Regulation of Saccharomyces Rad53 checkpoint kinase during adaptation from DNA damage-induced G2/M arrest. Mol Cell 7, 293-300 (2001)

139. Zierhut C and Diffley JF: Break dosage, cell cycle stage and DNA replication influence DNA double strand break response. EMBO J 27, 1875-1885 (2008)

140. Hirano Y, Fukunaga K, and Sugimoto K: Rif1 and Rif2 inhibit localization of Tel1 to DNA ends. Mol Cell 33, 312-322 (2009)

141. Martín V, Du LL, Rozenzhak S, and Russell P: Protection of telomeres by a conserved Stn1-Ten1 complex. Proc Natl Acad Sci USA 104, 14038-14043 (2007)

142. Song X, Leehy K, Warrington RT, Lamb JC, Surovtseva YV, and Shippen DE: STN1 protects chromosome ends in Arabidopsis thaliana. Proc Natl Acad Sci USA 105, 19815-19820 (2008)

143. Miyake Y, Nakamura M, Nabetani A, Shimamura S, Tamura M, Yonehara S, Saito M, and Ishikawa F: RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol Cell 36, 193-206 (2009)

144. Surovtseva YV, Churikov D, Boltz KA, Song X, Lamb JC, Warrington R, Leehy K, Heacock M, Price CM, and Shippen DE: Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes. Mol Cell 36, 207-218 (2009)

145. Qi H and Zakian VA: The Saccharomyces telomere-binding protein Cdc13p interacts with both the catalytic subunit of DNA polymerase alpha and the telomerase-associated Est1 protein. Genes Dev 14, 1777-1788 (2000)

146. Grossi S, Puglisi A, Dmitriev PV, Lopes M, and Shore D: Pol12, the B subunit of DNA polymerase alpha, functions in both telomere capping and length regulation. Genes Dev 18, 992-1006 (2004)

147. Goulian M, Heard CJ, and Grimm SL: Purification and properties of an accessory protein for DNA polymerase alpha/primase. J Biol Chem 265, 13221-13230 (1990)

148. Casteel DE, Zhuang S, Zeng Y, Perrino FW, Boss GR, Goulian M, and Pilz RB: A DNA polymerase alpha-primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells. J Biol Chem 284, 5807-5818 (2009)

149. Marcand S, Gilson E, and Shore D: A protein-counting mechanism for telomere length regulation in yeast. Science 275, 986-990 (1997)

150. Levy DL and Blackburn EH: Counting of Rif1p and Rif2p on Saccharomyces cerevisiae telomeres regulates telomere length. Mol Cell Biol 24, 10857-10867 (2004)

151. van Steensel B and de Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 385, 740-743 (1997)

152. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, and de Lange T: Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20, 1659-1668 (2000)

153. Li B and de Lange T: Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell 14, 5060-5068 (2003)

154. O'Connor MS, Safari A, Liu D, Qin J, and Songyang Z: The human Rap1 protein complex and modulation of telomere length. J Biol Chem 279, 28585-28591 (2004)

155. Loayza D and de Lange T: POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013-1018 (2003)

156. Kelleher C, Kurth I, and Lingner J: Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol Cell Biol 25, 808-818 (2005)

157. Lei M, Zaug AJ, Podell ER, and Cech TR: Switching human telomerase on and off with hPOT1 protein in vitro. J Biol Chem 280, 20449-20456 (2005)

158. McGee JS, Phillips JA, Chan A, Sabourin M, Paeschke K, and Zakian VA: Reduced Rif2 and lack of Mec1 target short telomeres for elongation rather than double-strand break repair. Nat Struct Mol Biol 17, 1438-1445 (2010)

159. Bilsland AE, Cairney CJ, and Keith WN: Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectives. J Cell Mol Med 15, 179-186 (2011)

160. Martínez P and Blasco MA: Role of shelterin in cancer and aging. Aging Cell 9, 653-666 (2010)

Abbreviations: DDR: DNA damage response, DSB: double-strand break, ssDNA: single-strand DNA, HR: homologous recombination, NHEJ: non homologous-end joining, Cdk: Cyclin-dependent kinase.

Key Words: Telomere, Shelterin, DSB, ssDNA, DNA damage response, Checkpoint, NHEJ, HR, Review

Send correspondence to: Maria Pia Longhese, Universita di Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy, Tel: 390264483425, Fax: 390264483565, E-mail:mariapia.longhese@unimib.it